Nicoletta Lanese
Nicoletta Lanese focuses on turning complex medical research and fast-moving health crises into clear, deeply reported stories that ordinary readers can use to understand what is at stake. Her coverage sits at the intersection of infectious disease, neuroscience and chronic conditions, with a consistent emphasis on explaining how new findings connect to everyday health and public policy. As health channel editor at Live Science, she combines hands-on reporting with commissioning and editing to shape the outlet’s overall agenda on medicine and public health.
Infectious disease and outbreak reporting
Lanese’s health beat is anchored in infectious disease, where she tracks both acute outbreaks and long-running threats such as antibiotic resistance and HIV. Her recent measles coverage follows fatalities and falling vaccination rates, situating local deaths within a national pattern of declining immunization that raises the risk of wider outbreaks. She treats outbreaks as both clinical and societal events, pairing expert analysis with clear explanations of how vaccine coverage, community behavior and public health infrastructure interact.
Antibiotic resistance is a recurring focus, and she covers it as a global pediatrics problem rather than a background trend. A feature on rising antibiotic resistance in children uses a large international study to illustrate how resistance patterns are changing around the world and what that means for frontline care. Her fellowship project on antibiotic stewardship across Japan and the U.S. extends that reporting into health-system practice, underscoring how prescribing norms and hospital protocols influence resistance over time.
Lanese also writes on long-running epidemics and the prospect of ending them, as in a feature arguing that the AIDS epidemic could be brought to an end within a decade if existing tools are deployed at scale. She profiles “superbugs” as a growing threat, explaining how certain pathogens evade existing antibiotics and what new approaches - from stewardship to novel drugs and infection control - might curb their spread.
On Live Science’s viruses and infections desk, she mixes these large-scale stories with pointed case studies, such as a toddler accidentally ingesting gonorrhea bacteria from a lab dish, to show how lab safety, human error and microbial risk intersect in real life.
Explaining medical research and emerging therapies
Beyond outbreaks, Lanese systematically follows new medical studies, drug candidates and diagnostic tools, and explains their implications without overhyping early-stage results.
Her work often starts from a specific paper or device - such as a “self-driving” rehabilitation system designed to help patients recover from heart attacks - and then lays out how the technology works, where it fits in existing care pathways, and what experts say about its real-world potential. Coverage of a blood test for Alzheimer’s disease takes the same approach, unpacking what the test measures, how accurate it is against current gold standards, and how clinicians expect to use it.
Lanese regularly reports on emerging therapies in mental health and autoimmune disease, including immune-based approaches to treating depression and other psychiatric symptoms. In these stories she focuses on mechanism and evidence: how an immune therapy is thought to influence brain circuits or inflammatory pathways, what the trial designs look like, and which outcomes matter most to patients. She also devotes attention to consumer-facing genetic and health tests, interviewing experts about the limits of accuracy and the risk that people misunderstand probabilistic results when they are marketed as definitive answers.
Recognition of major research awards and “America’s Nobel”–style prizes appears in her work as another way of tracking where the field is moving. In those pieces she profiles award-winning sleep and hemophilia research alongside high-profile advocacy for Parkinson’s disease, drawing out how scientific advances and patient advocacy can reinforce each other.
Across these stories, her distinguishing trait is a steady insistence on both methodological detail and practical context: readers are told what a study showed, how strong the evidence is, and what experts say it does and does not mean for care today.
Chronic conditions, neuroscience and the human body
Lanese spends substantial time on chronic and poorly understood conditions, bringing together cutting-edge lab work and lived experience. A feature on myalgic encephalomyelitis/chronic fatigue syndrome follows a milestone study that begins to explain the disease, while foregrounding patient voices who describe how the condition has upended their lives and what they hope from future treatments. Another high-profile piece on childhood obesity examines new guidelines calling for early and aggressive intervention, weighing potential benefits against safety concerns and social implications for children and families.
Her neuroscience reporting ranges from basic brain maps to highly specific case studies in athletics and sleep.
She has chronicled the development of a super-detailed map of the brain cells that keep people awake, using that work to explore broader questions about consciousness and sleep regulation. Features and news stories on narcolepsy - from dogs with narcolepsy that help scientists understand the disorder, to broader coverage of sleep research - translate complex neurobiology into accessible explanations of fatigue, collapse and circadian rhythms.
Lanese also uses everyday phenomena to illuminate how the body and brain operate, such as reporting on men’s daily hormone cycles and their relationship to measurable changes in brain volume over the course of a day. Coverage of elite athletes, including an exploration of what happens inside Simone Biles’ brain when the “twisties” set in, connects neuroscience to real-world performance and anxiety. Across these subjects, her work returns to the same core move: describe the underlying biology in plain language, then show how that biology surfaces in symptoms, diagnoses and personal narratives.
Shaping a broad health agenda
As health channel editor, Lanese oversees and contributes a large volume of news and features each month, spanning infections, cancer, cardiovascular disease, neuroscience, aging and more.
She commissions and edits coverage of the latest medical studies and drug developments while also writing evergreen explainers on how specific organs, systems and diseases work. Her end-of-year and forward-looking pieces, including a review of standout health stories from measles outbreaks to AI-made viruses and predictions about medical breakthroughs and public health shifts in 2026, show her role in setting the channel’s long-range editorial priorities.
Lanese’s byline appears widely beyond Live Science, including in science and medical magazines and news outlets that focus on research, clinical practice and the environment.
Across those venues she maintains the same core approach: precise reporting on health and medicine, careful use of expert voices, and a sustained effort to make complex science intelligible without diluting its nuance. That combination of editorial leadership, outbreak fluency and deep comfort with medical literature distinguishes her from a general health reporter and defines the kind of stories she is best equipped to handle.
4 more health journalists.
Alanna Smith
Alanna Smith is a national health reporter whose work links health policy and politics to real access to care, with a constant focus on health equity, infectious disease and the toxic drug crisis. She reports for The Globe and Mail on infectious diseases, hospitals and long-term care, mental health, drug policy and the pressures on health systems in Western Canada. Her stories connect big-picture decisions to patients, families, front-line workers and volunteers, showing how funding, privatization and federal standards shape public care. She has covered trauma care inequities, proposed public‑private models in Alberta, drug toxicity and overdose policy, respiratory virus surges, measles elimination, gene‑editing advances and gender‑affirming health care laws. Her work combines narrative reporting, data, legal and policy analysis, and has been recognized by national journalism and press freedom organizations.
Allan Levine
Allan Levine is a historian and author whose journalism uses the past to explain present-day issues. He writes for the Winnipeg Free Press, including the Now & Then column, which examines current events through history. His subjects include public health, disease, medical treatment, health systems, politics, social conflict, strikes, wars, antisemitism and Canadian public life. His polio reporting traces Manitoba epidemics, hospital pressures, treatment, mortality and the arrival of vaccines through archival data and medical history. He also writes about the Winnipeg General Strike and Jewish communities, including discrimination, rights and security. His work draws on books about Canadian political leaders, Jewish history and the wartime economy, including The Dollar A Year Men. He writes long-form, analytical pieces that combine dates, statistics, policy decisions and narrative storytelling to connect people and institutions with broader historical change.
Angela Amato
Angela Amato is a digital news producer with CTV News, and her coverage is distinct for linking health research and public safety concerns to legal and policy decisions that shape daily life. She reports on health, justice, politics, business, arts and culture, crime and public-interest stories. Her health work covers academic and clinical research, including studies on vaping and lung blood flow, exercise tolerance and early heart dysfunction in young adults. She also reports on motorcycle gang arrests, homicide and death investigations, Indigenous justice stories, wildfire evacuations, ambulance contracts, property taxes, labour negotiations and political advocacy rules. She explains complex findings in plain language and stays close to documents, data and expert sources. Her background includes investigative and daily newsrooms, and she has earned nominations for national journalism awards.
Apoorva Mandavilli
Apoorva Mandavilli covers the collision of infectious disease science, vaccine policy and public health agencies for The New York Times, following how research, regulation and politics shape outbreaks and access to vaccines. She reports on science and global health with a steady focus on infectious diseases and pandemics, including Covid-19, mpox, H.I.V., malaria and tuberculosis, treating them as ongoing global threats. Her work explains complex epidemiology and virology in clear narratives about risk, evidence and the consequences of scientific decisions. She repeatedly returns to vaccine policy, law and misinformation, tracing how court fights and agency disputes affect immunization schedules and public trust. She also reports on global health programs, funding cuts and inequity in care and technology. A longtime science journalist and former founding editor in chief of Spectrum, she has written widely on science and health and received major honors for medical science reporting and pandemic coverage.